Iqvia price target raised to $270 from $239 at TD Cowen

TD Cowen raised the firm’s price target on Iqvia to $270 from $239 and keeps an Outperform rating on the shares. The firm thinks underlying fundamentals are improving in TAS as the pipeline is at a record high and discretionary businesses saw some sequential improvement in 4Q23. Cowen believes guidance leaves room for outperformance in 2024.